X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
theracurmin (21) 21
curcumin (16) 16
index medicus (9) 9
humans (7) 7
pharmacology & pharmacy (7) 7
animals (6) 6
bioavailability (6) 6
biological availability (6) 6
curcumin - administration & dosage (6) 6
curcumin - pharmacokinetics (5) 5
oncology (5) 5
cancer (4) 4
care and treatment (4) 4
curcumin - pharmacology (4) 4
encapsulated curcumin (4) 4
male (4) 4
nf-kappa-b (4) 4
original (4) 4
administration, oral (3) 3
apoptosis (3) 3
chemopreventive agent (3) 3
chronic obstructive pulmonary disease (3) 3
curcumin - adverse effects (3) 3
diabetes mellitus (3) 3
disease models, animal (3) 3
female (3) 3
gene expression (3) 3
heart failure (3) 3
i clinical-trial (3) 3
liver dysfunction (3) 3
medicine & public health (3) 3
nuclear factor-kappa b (3) 3
oxidative stress (3) 3
proliferation (3) 3
rats (3) 3
solubility (3) 3
absorption (2) 2
adult (2) 2
alzheimer's disease (2) 2
anti-inflammatory (2) 2
antineoplastic agents, phytogenic - administration & dosage (2) 2
antineoplastic agents, phytogenic - adverse effects (2) 2
antineoplastic agents, phytogenic - pharmacokinetics (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
antioxidant (2) 2
antioxidative activity (2) 2
cancer cells (2) 2
cancer research (2) 2
chemotherapy (2) 2
curcumin - analogs & derivatives (2) 2
curcumin - therapeutic use (2) 2
cyclooxygenase-2 (2) 2
dose-response relationship, drug (2) 2
down-regulation (2) 2
factor-kappa-b (2) 2
gastroenterology & hepatology (2) 2
health aspects (2) 2
highly bioavailable curcumin (2) 2
in-vitro (2) 2
induction (2) 2
inflammation (2) 2
middle aged (2) 2
myocardial-infarction (2) 2
nanoparticles (2) 2
nanotechnology (2) 2
nf-kappa b - antagonists & inhibitors (2) 2
oral bioavailability (2) 2
original article (2) 2
pancreatic cancer (2) 2
pancreatic neoplasms - drug therapy (2) 2
pancreatic neoplasms - metabolism (2) 2
patients (2) 2
pharmacology/toxicology (2) 2
phytotherapy (2) 2
quality of life (2) 2
recognition memory (2) 2
regulated gene-products (2) 2
spatial memory (2) 2
synaptic component (2) 2
4-hydroxynonenal (1) 1
abdominal surgery (1) 1
activation (1) 1
active transport, cell nucleus - drug effects (1) 1
adenomatous polyposis coli (1) 1
adenomatous polyposis coli - drug therapy (1) 1
adenomatous polyposis coli - genetics (1) 1
adenomatous polyposis coli - pathology (1) 1
adenomatous polyposis coli protein - genetics (1) 1
administration, ophthalmic (1) 1
advanced pancreatic-cancer (1) 1
aged (1) 1
aged, 80 and over (1) 1
alcohols (1) 1
aldehyde reductase (1) 1
aldehyde reductase - antagonists & inhibitors (1) 1
aldehyde reductase - isolation & purification (1) 1
aldehydes - metabolism (1) 1
aldose reductase (1) 1
alpha (1) 1
alternative medicine (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer chemotherapy and pharmacology, ISSN 1432-0843, 2013, Volume 71, Issue 6, pp. 1521 - 1530
A growing number of preclinical studies have demonstrated that curcumin could be a promising anticancer drug; however, poor bioavailability has been the major... 
Medicine & Public Health | Gemcitabine | Pancreatic cancer | Oncology | Cancer Research | Curcumin | Theracurmin | Bioavailability | Pharmacology/Toxicology | APOPTOSIS | Theracurmin (R) | CLINICAL-TRIAL | FACTOR-KAPPA-B | PROLIFERATION | ENCAPSULATED CURCUMIN | ADVANCED PANCREATIC-CANCER | THERAPY | ONCOLOGY | SUPPRESSES GROWTH | CHEMOPREVENTIVE AGENT | PHARMACOLOGY & PHARMACY | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Pancreatic Neoplasms - metabolism | Antineoplastic Combined Chemotherapy Protocols - chemistry | Curcumin - chemistry | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Biological Availability | Male | Biliary Tract Neoplasms - mortality | Curcumin - administration & dosage | Dose-Response Relationship, Drug | Pancreatic Neoplasms - drug therapy | Biliary Tract Neoplasms - metabolism | Aged, 80 and over | Drug Compounding | Female | Pancreatic Neoplasms - mortality | Biliary Tract Neoplasms - drug therapy | Cytokines - immunology | NF-kappa B - antagonists & inhibitors | Drug Administration Schedule | Drug Stability | Curcumin - pharmacokinetics | Solubility | Curcumin - adverse effects | Disease-Free Survival | Maximum Tolerated Dose | Quality of Life | Aged | Cytokines - antagonists & inhibitors | Medical colleges | Cancer patients | Care and treatment | Chemotherapy | Safety and security measures | Cancer
Journal Article
Journal Article
PharmaNutrition, ISSN 2213-4344, 10/2015, Volume 3, Issue 4, pp. 123 - 130
•Development of highly bioavailable curcumin (Theracurmin).•Effect of curcumin on cancer.•Effect of curcumin on cardiovascular disease.•Effect of curcumin... 
Theracurmin | Antioxidant | Highly bioavailable curcumin | Anti-inflammatory
Journal Article
Journal Article
Toxicological research (Seoul), ISSN 1976-8257, 2019, Volume 35, Issue 4, pp. 403 - 412
Curcumin, a hydrophobic polyphenol isolated from the . plant, has many pharmacological properties, including antioxidant, anti-inflammatory, and... 
Fatty liver | High fat diet (HFD) | Theracurmin | Curcumin | Nonalcoholic fatty liver disease (NAFLD) | Original | Steatosis | 예방의학
Journal Article
Journal Article
Frontiers in Oncology, ISSN 2234-943X, 2013, Volume 3, p. 137
In Western countries the incidence of the esophageal adenocarcinoma (EAC) has risen at a more rapid rate than that of any other malignancy. Despite intensive... 
Curcumin | Theracurmin | Dendritic cell vaccines | Nano-curcumin | Esophageal adenocarcinoma | T cell responses | Tumor Microenvironment | nano-curcumin | Dendritic Cell vaccines
Journal Article
JER, ISSN 2288-176X, 12/2017, Volume 13, Issue 6, pp. 684 - 692
The purpose of this study was to investigate the short-term of Theracurmin dose and exercise type on pain, walking ability, and muscle function in patients... 
Theracurmin | Exercise | Knee osteoarthritis | Pain | Walking ability | 심리과학
Journal Article
Biological & pharmaceutical bulletin, ISSN 1347-5215, 2013, Volume 36, Issue 11, pp. 1708 - 1714
Journal Article
by Kim, J and Huang, Z and Goo, N and Bae, HJ and Jeong, Y and Park, HJ and Cai, M and Cho, K and Jung, SY and Bae, SK and Ryu, JH
BIOMOLECULES & THERAPEUTICS, ISSN 1976-9148, 05/2019, Volume 27, Issue 3, pp. 327 - 335
As the elderly population is increasing, Alzheimer's disease (AD) has become a global issue and many clinical trials have been conducted to evaluate treatments... 
Recognition memory | Antioxidative activity | CURCUMIN | ALZHEIMERS-DISEASE | NEURODEGENERATION | Theracurmin | Synaptic component | SHORT-TERM-MEMORY | SYNAPTOPHYSIN | HIPPOCAMPUS | CONNECTIVITY | INFLAMMATION | OBJECT RECOGNITION | PHARMACOLOGY & PHARMACY | DEFICITS | Alzheimer's disease | Spatial memory | Alzheimer’s disease | Original | 약학
Journal Article
Journal Article
CLINICAL INTERVENTIONS IN AGING, ISSN 1178-1998, 2020, Volume 15, pp. 691 - 693
Chemobrain is one of the problems that may arise during or after treatment and there is currently no specific treatment for this condition. Our case was a... 
chemobrain | CURCUMIN | elderly | Theracurmin | cognitive impairment | cancer | IMPAIRMENT | GERIATRICS & GERONTOLOGY | Executive function | Laboratories | Brain cancer | Memory | Cognitive ability | Breast cancer | Medical diagnosis | Gene expression | Apolipoproteins | Patients | Cancer therapies | Outpatient care facilities | Quality of life | Chemotherapy | Older people | Geriatrics | theracurmin
Journal Article
Yakugaku zasshi, ISSN 0031-6903, 2018, Volume 138, Issue 10, pp. 1263 - 1269
Hemodynamic stresses, including hypertension and myocardial infarction, activate neurohumoral factors such as the sympathetic nervous system and the... 
heart failure | Theracurmin | diabetes mellitus | liver dysfunction | curcumin | chronic obstructive pulmonary disease
Journal Article
Journal Article
Biomolecules & therapeutics, ISSN 1976-9148, 2019, Volume 27, Issue 3, pp. 327 - 335
As the elderly population is increasing, Alzheimer's disease (AD) has become a global issue and many clinical trials have been conducted to evaluate treatments... 
Recognition memory | Antioxidative activity | Theracurmin | Alzheimer's disease | Synaptic component | Spatial memory
Journal Article
Cancer science, ISSN 1349-7006, 2020, Volume 111, Issue 4, pp. 1367 - 1374
Colorectal cancer (CRC) is the second leading cause of cancer death worldwide. Therefore, it is important to establish useful methods for preventing CRC. One... 
colorectal cancer chemoprevention | Theracurmin | nuclear factor‐κB | min mice | curcumin | Intestines - drug effects | Inflammation - pathology | Curcumin - analogs & derivatives | Colorectal Neoplasms - genetics | Humans | Adenomatous Polyposis Coli - pathology | Intestinal Polyps - genetics | Intestinal Polyps - drug therapy | Inflammation - drug therapy | Colorectal Neoplasms - drug therapy | Gene Expression Regulation, Neoplastic - drug effects | Adenomatous Polyposis Coli - genetics | Disease Models, Animal | Adenomatous Polyposis Coli Protein - genetics | Intestines - pathology | Interleukin-6 - genetics | HCT116 Cells | Curcumin - pharmacology | Chemokine CCL2 - genetics | Carcinogenesis - drug effects | Animals | NF-kappa B - genetics | Adenomatous Polyposis Coli - drug therapy | Intestinal Polyps - pathology | Inflammation - genetics | Mice | Colorectal Neoplasms - pathology | ACTIVATION | CYCLOOXYGENASE-2 | CANCER CELLS | HYPERLIPIDEMIA | nuclear factor-kappa B | INDUCTION | SUPPRESSION | ONCOLOGY | NF-KAPPA-B | Chemopreventive agents | Colorectal carcinoma | Familial adenomatous polyposis | Colorectal cancer | Clinical trials | Inflammation | Hydrophobicity | Gene expression | Experiments | Small intestine | Carcinogenesis | Mutants | Adenomatous polyposis coli | Monocytes | Colon cancer | Intestine | Plasmids | Monocyte chemoattractant protein | Curcumin | Polyps | Index Medicus | Original
Journal Article